Varma Mutual Pension Insurance Co Grows Stock Holdings in McKesson Corporation $MCK

Varma Mutual Pension Insurance Co grew its stake in shares of McKesson Corporation (NYSE:MCK) by 28.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 21,853 shares of the company’s stock after acquiring an additional 4,900 shares during the period. Varma Mutual Pension Insurance Co’s holdings in McKesson were worth $16,882,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of MCK. Solstein Capital LLC increased its position in shares of McKesson by 171.4% in the second quarter. Solstein Capital LLC now owns 38 shares of the company’s stock valued at $28,000 after buying an additional 24 shares in the last quarter. State of Wyoming purchased a new position in shares of McKesson during the 2nd quarter worth $29,000. Hopwood Financial Services Inc. purchased a new stake in McKesson in the third quarter valued at approximately $31,000. Delos Wealth Advisors LLC purchased a new position in shares of McKesson in the 2nd quarter worth about $35,000. Finally, Abound Wealth Management boosted its position in McKesson by 104.3% during the 3rd quarter. Abound Wealth Management now owns 47 shares of the company’s stock worth $37,000 after purchasing an additional 24 shares during the period. 85.07% of the stock is owned by institutional investors and hedge funds.

McKesson Price Performance

Shares of NYSE:MCK opened at $916.08 on Friday. The stock has a market capitalization of $112.21 billion, a P/E ratio of 26.35, a P/E/G ratio of 1.53 and a beta of 0.40. The business has a 50-day moving average of $837.61 and a two-hundred day moving average of $785.95. McKesson Corporation has a fifty-two week low of $585.22 and a fifty-two week high of $971.93.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating the consensus estimate of $9.19 by $0.15. The company had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The company’s revenue for the quarter was up 11.4% compared to the same quarter last year. During the same quarter last year, the company posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, research analysts expect that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be issued a $0.82 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. McKesson’s dividend payout ratio (DPR) is 9.43%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on MCK shares. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of McKesson in a report on Wednesday, December 10th. UBS Group upped their price objective on McKesson from $920.00 to $980.00 and gave the company a “buy” rating in a report on Thursday, November 6th. Robert W. Baird set a $968.00 price target on McKesson in a report on Wednesday, January 14th. Morgan Stanley reiterated an “overweight” rating and issued a $966.00 target price on shares of McKesson in a report on Thursday, January 29th. Finally, Zacks Research downgraded McKesson from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 25th. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $937.07.

Insider Buying and Selling

In other McKesson news, EVP Thomas L. Rodgers sold 276 shares of the stock in a transaction on Monday, January 5th. The shares were sold at an average price of $816.18, for a total value of $225,265.68. Following the completion of the sale, the executive vice president directly owned 2,268 shares of the company’s stock, valued at $1,851,096.24. This represents a 10.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. Additional details regarding this sale are available in the official SEC disclosure. 0.08% of the stock is owned by insiders.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.